Abstract Background: In May 2026, the World Health Organization (WHO) reported a multi-national cluster of Andes hantavirus (ANDV) infections linked to the cruise vessel M/V Hondius. The outbreak generated international concern because ANDV is associated with hantavirus pulmonary syndrome (HPS), a severe zoonotic disease with reported case-fatality rate (CFR) of 35-50%, despite limited person-to-person transmission. This rapid mini-review aimed to examine the virologic, epidemiologic, and public health significance of the ANDV outbreak while highlighting why evidence-based vigilance is more appropriate than disproportionate societal panic. Methods: We conducted a rapid mini-review of the virologic, epidemiologic, phylogenetic, clinical, and public health dimensions of hantavirus infections with a focus on ANDV using literature identified through Google Scholar and publicly available reports from the WHO, the United States Centers for Disease Control and Prevention (CDC), and international public health agencies up to 14 May 2026. Results: As of 13 May 2026, 11 ANDV outbreak-associated cases, including three deaths (CFR, 27%), had been reported. Eight cases were laboratory-confirmed for ANDV infection, two were classified as probable, and one remained under investigation. Current evidence indicates that ANDV transmission remains epidemiologically constrained by low secondary attack rates, prolonged close contact requirements, limited asymptomatic spread, and absence of sustained community spread. The review identified several major public health implications, including the importance of early clinical recognition of HPS, implementation of infection-control measures, coordinated multi national surveillance, rapid diagnostic preparedness, and timely risk communication capable of balancing vigilance with avoidance of disproportionate societal alarm. Conclusions: The M/V Hondius ANDV outbreak highlights that pathogens capable of causing severe disease are not necessarily capable of sustaining efficient transmission. Although ANDV warrants international surveillance and preparedness because of its substantial clinical severity and limited person-to-person transmission, currently available evidence suggests that the broader public health risk remains relatively low. Nevertheless, ongoing epidemiologic monitoring and international coordination remain essential as additional data emerge. Effective ANDV outbreak management therefore depends upon coordinated public health response, transparent risk communication, and evidence-based vigilance while avoiding disproportionate societal alarm.